|
Real-time Estimate
Cboe BZX
19:27:51 02/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 259.24 USD | -0.29% |
|
-1.71% | +13.09% |
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 08-27 | AbbVie Seeks EU Approval for Subcutaneous Skyrizi Induction in Crohn's Disease | MT |
| Market Cap | 459B 0 0 0 0 0 0 0 0 0 0 0 0 | P/E 2026 * |
33.2x | P/E 2027 * | 24.5x |
|---|---|---|---|---|---|
| Enterprise Value | 520B 0 0 0 0 0 0 0 0 0 0 0 0 | EV / Sales 2026 * |
7.69x | EV / Sales 2027 * | 6.95x |
| Free-Float |
95.71% | Yield 2026 * |
2.64% | Yield 2027 * | 2.77% |
Last Transcript : AbbVie Inc.
| 1 day | -0.30% | ||
| 1 week | -1.71% | ||
| Current month | +0.78% | ||
| 1 month | +5.43% | ||
| 3 months | +19.97% | ||
| 6 months | +10.31% | ||
| Current year | +13.09% |
| 1 week | 252.33 |  | 262.97 |
| 1 month | 241.2 | | 266.96 |
| Current year | 190.75 | | 267.47 |
| 1 year | 190.75 | | 267.47 |
| 3 years | 135.85 | | 267.47 |
| 5 years | 105.56 | | 267.47 |
| 10 years | 55.06 | | 267.47 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 01/07/2024 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 23/06/2022 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 01/01/2013 |
William Burnside
BRD | Director/Board Member | 74 | 01/01/2013 |
Ed Rapp
BRD | Director/Board Member | 69 | 01/01/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/14/26 A | Exercice | Executive/Senior Manager | 98,130 | 0.0056% | ||
| 6/30/26 A | Free | Director | 62 | 0.0000% | ||
| 6/30/26 A | Free | Director | 134 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.29% | -1.71% | +21.94% | +76.87% | 459B | |
| +0.35% | -2.22% | +58.19% | +108.35% | 1,034B | |
| +1.40% | +1.45% | +53.84% | +70.48% | 654B | |
| +0.49% | -5.19% | +33.28% | +35.53% | 343B | |
| +0.27% | +3.26% | +29.76% | +47.50% | 307B | |
| +0.12% | -2.11% | +0.60% | +12.03% | 251B | |
| -0.15% | -1.05% | +51.85% | +71.53% | 237B | |
| +2.64% | -1.08% | -15.85% | -53.97% | 202B | |
| -0.39% | +0.63% | +32.22% | +98.27% | 186B | |
| +1.14% | +1.93% | +15.47% | -18.47% | 163B | |
| Average | +0.51% | -2.60% | +28.13% | +44.81% | 383.43B | |
| Weighted average by Cap. | +0.43% | -3.18% | +37.48% | +63.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.58B 0 0 0 0 0 0 0 0 0 0 0 0 | 73.52B 0 0 0 0 0 0 0 0 0 0 0 0 |
| Net income | 13.86B 0 0 0 0 0 0 0 0 0 0 0 0 | 18.91B 0 0 0 0 0 0 0 0 0 0 0 0 |
| Net Debt | 60.49B 0 0 0 0 0 0 0 0 0 0 0 0 | 51.66B 0 0 0 0 0 0 0 0 0 0 0 0 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/09/26 | $258.38 | -0.62% | 1,515,281 |
| 01/09/26 | $259.99 | +1.39% | 3,866,739 |
| 31/08/26 | $256.42 | +0.37% | 4,315,487 |
| 28/08/26 | $255.48 | -1.03% | 3,224,862 |
| 27/08/26 | $258.15 | -1.81% | 4,764,797 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
Select your edition
All financial news and data tailored to specific country editions
